172 related articles for article (PubMed ID: 26189009)
1. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis.
Driessen J; Olson ZD; Jamison DT; Verguet S
Soc Sci Med; 2015 Aug; 139():115-22. PubMed ID: 26189009
[TBL] [Abstract][Full Text] [Related]
2. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
[TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
[TBL] [Abstract][Full Text] [Related]
5. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
6. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
Wichmann O; Ultsch B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
[TBL] [Abstract][Full Text] [Related]
8. Inequalities in measles immunization coverage in Ethiopia: a cross-sectional analysis of demographic and health surveys 2000-2016.
Shibre G; Zegeye B; Idriss-Wheeler D; Yaya S
BMC Infect Dis; 2020 Jul; 20(1):481. PubMed ID: 32635891
[TBL] [Abstract][Full Text] [Related]
9. Maintaining high rates of measles immunization in Africa.
Lessler J; Moss WJ; Lowther SA; Cummings DA
Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
[TBL] [Abstract][Full Text] [Related]
10. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh.
Koehlmoos TP; Uddin J; Sarma H
J Infect Dis; 2011 Jul; 204 Suppl 1():S90-7. PubMed ID: 21666219
[TBL] [Abstract][Full Text] [Related]
11. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
[TBL] [Abstract][Full Text] [Related]
12. Progress in measles mortality reduction in Ethiopia, 2002-2009.
Mitiku K; Bedada T; Masresha BG; Kegne W; Nafo-Traoré F; Tesfaye N; Yigzaw A
J Infect Dis; 2011 Jul; 204 Suppl 1():S232-8. PubMed ID: 21666166
[TBL] [Abstract][Full Text] [Related]
13. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
[TBL] [Abstract][Full Text] [Related]
14. Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis.
Verguet S; Murphy S; Anderson B; Johansson KA; Glass R; Rheingans R
Vaccine; 2013 Oct; 31(42):4902-10. PubMed ID: 23871824
[TBL] [Abstract][Full Text] [Related]
15. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
[TBL] [Abstract][Full Text] [Related]
16. The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns.
Hagedorn BL; Dabbagh A; McCarthy KA
Vaccine; 2019 Sep; 37(41):6093-6101. PubMed ID: 31471145
[TBL] [Abstract][Full Text] [Related]
17. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
[TBL] [Abstract][Full Text] [Related]
18. Impact of mass measles campaigns among children less than 5 years old in Uganda.
Nanyunja M; Lewis RF; Makumbi I; Seruyange R; Kabwongera E; Mugyenyi P; Talisuna A
J Infect Dis; 2003 May; 187 Suppl 1():S63-8. PubMed ID: 12721893
[TBL] [Abstract][Full Text] [Related]
19. Measles control in Sub-Saharan Africa: South Africa as a case study.
Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
[TBL] [Abstract][Full Text] [Related]
20. A review of measles supplementary immunization activities and the implications for Pacific Island countries and territories.
Clements CJ; Soakai TS; Sadr-Azodi N
Expert Rev Vaccines; 2017 Feb; 16(2):161-174. PubMed ID: 27690704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
